We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

News   Mar 01, 2019 | Original Press Release from the Advanced Science Research Center at the Graduate Center of the City University of New York

 
Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

Fumaric Acid Ester Metabolites act as a regulator of the micro RNA MIR-21, which is necessary to create the brain-homing T cells that are active in multiple sclerosis. Credit: Carter Eitreim

 
 
Advertisement
 

RELATED ARTICLES

Innovative Technique Measures Pressure in the Skull Using the Brain's Natural Resonance Frequency

News

Currently, the only way to measure pressure inside the skull, formally called intracranial pressure (ICP), is by using invasive techniques that insert a catheter or sensor. Researchers have been hunting for better ways of measuring ICP. The latest proposed solution can predict ICP by monitoring resonance frequencies within the brain.

READ MORE

Teen Cannabis Use Linked to Adult Insomnia

News

Smoke a lot of weed as a teenager, and when you reach adulthood you’ll be more likely to have trouble falling or staying asleep, according to a new CU Boulder study of more than 1,800 twins.

READ MORE

Discovering Molecules That Alter Our Circadian Clock

News

Researchers have uncovered molecules that act to lengthen the period of the circadian clock, shedding light on their mechanisms of action.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE